Screener
Acadia Pharmaceuticals ACAD Price / earnings
Price / earnings at other companies
Other financials
Where this comes from
Calculated from Acadia Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Acadia Pharmaceuticals’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333243
FAQ
- What is Acadia Pharmaceuticals's price / earnings?
- Acadia Pharmaceuticals (ACAD) reported price / earnings of 11.4× in Q2 2026.
- How has Acadia Pharmaceuticals's price / earnings changed year-over-year?
- Acadia Pharmaceuticals's price / earnings decreased by 32.6% year-over-year, from 16.9× to 11.4×.
- What does price / earnings mean?
- Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.
Ask your AI about Acadia Pharmaceuticals's price / earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude